APA Citation

Pemmaraju, N., Kantarjian, H., Kadia, T., Cortes, J., Borthakur, G., Newberry, K., . . . Verstovsek, S. (2014). A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk.

Citação norma Chicago

Pemmaraju, Naveen, et al. "A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia." Clin Lymphoma Myeloma Leuk 2014.

MLA Citation

Pemmaraju, Naveen, et al. "A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia." Clin Lymphoma Myeloma Leuk 2014.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.